Chairman & Chief Executive Officer
Mr. Peterson has been constantly involved in numerous early stage ventures in the public and private sectors, with an emphasis in healthcare and technology while assisting such companies in advisory and investment initiatives. Jeffrey has been our V.P. Finance since July 2012. Before such time he served in various capacities within ActiveCare from July 2011 until July 2012. From January 2010 until July 2011 Jeffrey was the Director of Investor Relations for SecureAlert, our former parent corporation. Prior to joining SecureAlert, he was an owner of Alpine Securities, a stock brokerage firm in Utah, where his duties included Broker, Market Maker, Communications Officer and AML Officer, while holding the following FINRA security licenses: 7, 63, 55, and 24. Jeffrey graduated from the University of Utah with a Bachelor of Arts Degree in Finance and Business Administration, while also being a founding member of the University Venture Fund. Jeffrey sits on our board of directors, and currently holds board observatory seats with Juneau Biosciences and CoNextions Medical.
Mr. Welgos joined our board of directors in June 2009. He has a BS in Chemical Engineering from the Newark College of Engineering (1962) where he was elected to Who’s Who in American Universities and Colleges and the the school’s Athletic Hall Of Fame. He worked for 38 years with Allied Signal Corp (now Honeywell International). He progressed through various technical department management positions in the Engineered Plastics area and then moved into the commercial side of the business, where he served as the Manager, North American Distributor Sales and ultimately Director of International Operations. It was here that he established distribution networks throughout the Pacific Rim and South America. During this period, joint ventures were created with Lucky Goldstar in Korea, Japan Synthetic Rubber in Japan and Duromer Industries Ltd. in Australia.. He retired from Allied Signal Corp in 2000.
Bradley C. Robinson
Mr. Robinson is the Chief Executive Officer of Predictive Technology Group, Inc. Mr. Robinson has experience developing and structuring early stage ventures in the areas of pharmaceuticals, medical device and information technology. Mr. Robinson was a founding member of three such ventures in healthcare, one of which (Specialized Health Products International, Inc.) was publicly traded until its acquisition by C.R. Bard. Predictive Technology Group, Inc. (“PRED”) develops and commercializes discoveries and technologies involved in novel molecular diagnostic and stem cell/pharmaceutical therapeutic products. Mr. Robinson was the Chief Executive Officer and co-founder of Infusive Technologies, LLC, which resulted in an asset acquisition by Sagent Pharmaceuticals, Inc. As part of the acquisition, Mr. Robinson became President of the medical device division of Sagent Pharmaceuticals. Sagent Pharmaceuticals is a specialty injectable pharmaceutical products company. Mr. Robinson left Sagent Pharmaceuticals to become Vice President of Business Development of Juneau Biosciences, LLC (“Juneau”). Juneau develops and commercializes genetic tests related to women’s healthcare. While at Juneau, he was responsible for developing strategic partnerships and assisted in financing transactions.
Mr. Robinson earned an MBA/MIM from the Graduate School of International Management (Thunderbird).